State AGs urge Pennsylvania court to select dermatology lawsuit as bellwether

A Connecticut-led group of states has argued that its lawsuit alleging collusion in markets for dermatological products should be the first to go to trial in sprawling multidistrict litigation accusing generic drug manufacturers of price-fixing and market allocation.


Get unlimited access to all Global Competition Review content